MX2021015137A - Profarmaco de succinato, composiciones que contienen profarmaco de succinato y usos de los mismos. - Google Patents
Profarmaco de succinato, composiciones que contienen profarmaco de succinato y usos de los mismos.Info
- Publication number
- MX2021015137A MX2021015137A MX2021015137A MX2021015137A MX2021015137A MX 2021015137 A MX2021015137 A MX 2021015137A MX 2021015137 A MX2021015137 A MX 2021015137A MX 2021015137 A MX2021015137 A MX 2021015137A MX 2021015137 A MX2021015137 A MX 2021015137A
- Authority
- MX
- Mexico
- Prior art keywords
- succinate prodrug
- prodrug
- compositions containing
- succinate
- nutricosmetics
- Prior art date
Links
- 239000000651 prodrug Substances 0.000 title abstract 3
- 229940002612 prodrug Drugs 0.000 title abstract 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000002407 ATP formation Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 210000003470 mitochondria Anatomy 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/20—Esters of monothiocarboxylic acids
- C07C327/30—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Psychology (AREA)
- Birds (AREA)
- Cardiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201970382 | 2019-06-19 | ||
| DKPA201970383 | 2019-06-19 | ||
| DKPA201970384 | 2019-06-19 | ||
| PCT/EP2020/066923 WO2020254484A1 (en) | 2019-06-19 | 2020-06-18 | Succinate prodrug, compositions containing the succinate prodrug and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021015137A true MX2021015137A (es) | 2022-01-18 |
Family
ID=71130953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021015137A MX2021015137A (es) | 2019-06-19 | 2020-06-18 | Profarmaco de succinato, composiciones que contienen profarmaco de succinato y usos de los mismos. |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11565998B2 (https=) |
| EP (2) | EP4360708A3 (https=) |
| JP (2) | JP7699551B2 (https=) |
| KR (1) | KR102871719B1 (https=) |
| CN (1) | CN113993842B (https=) |
| AU (1) | AU2020298031B2 (https=) |
| CA (1) | CA3143112A1 (https=) |
| IL (1) | IL288990B2 (https=) |
| MA (1) | MA56506A (https=) |
| MX (1) | MX2021015137A (https=) |
| WO (1) | WO2020254484A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL288990B2 (en) * | 2019-06-19 | 2025-09-01 | Abliva Ab | Succinate drug meters, preparations containing the succinate drug meters and its uses |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9612331D0 (en) | 1996-06-13 | 1996-08-14 | Leo Pharm Prod Ltd | Chemical compounds |
| AUPR059400A0 (en) | 2000-10-06 | 2000-11-02 | Bar-Ilan University | Formaldehyde-releasing prodrugs |
| PL3129016T3 (pl) | 2014-04-08 | 2018-10-31 | Neurovive Pharmaceutical Ab | Nowe przepuszczalne dla komórek związki bursztynianu |
| SG11201607908QA (en) * | 2014-04-08 | 2016-10-28 | Neurovive Pharmaceutical Ab | Succinate prodrugs for use in the treatment of lactic acidosis or drug-induced side-effects due to complex i-related impairment of mitochondrial oxidative phosphorylation |
| IL288990B2 (en) * | 2019-06-19 | 2025-09-01 | Abliva Ab | Succinate drug meters, preparations containing the succinate drug meters and its uses |
-
2020
- 2020-06-17 IL IL288990A patent/IL288990B2/en unknown
- 2020-06-18 US US17/615,408 patent/US11565998B2/en active Active
- 2020-06-18 CA CA3143112A patent/CA3143112A1/en active Pending
- 2020-06-18 AU AU2020298031A patent/AU2020298031B2/en active Active
- 2020-06-18 KR KR1020227002009A patent/KR102871719B1/ko active Active
- 2020-06-18 JP JP2021575316A patent/JP7699551B2/ja active Active
- 2020-06-18 CN CN202080043350.XA patent/CN113993842B/zh active Active
- 2020-06-18 MX MX2021015137A patent/MX2021015137A/es unknown
- 2020-06-18 EP EP24152013.9A patent/EP4360708A3/en not_active Withdrawn
- 2020-06-18 WO PCT/EP2020/066923 patent/WO2020254484A1/en not_active Ceased
- 2020-06-18 EP EP20734337.7A patent/EP3986862B1/en active Active
- 2020-06-18 MA MA056506A patent/MA56506A/fr unknown
-
2022
- 2022-09-14 US US17/944,751 patent/US12162824B2/en active Active
-
2024
- 2024-10-08 JP JP2024176276A patent/JP7827801B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3986862A1 (en) | 2022-04-27 |
| IL288990A (en) | 2022-02-01 |
| EP3986862C0 (en) | 2024-01-24 |
| US20230033294A1 (en) | 2023-02-02 |
| WO2020254484A1 (en) | 2020-12-24 |
| EP4360708A3 (en) | 2024-12-25 |
| JP7827801B2 (ja) | 2026-03-10 |
| US12162824B2 (en) | 2024-12-10 |
| JP2022538009A (ja) | 2022-08-31 |
| AU2020298031B2 (en) | 2025-12-18 |
| BR112021024510A2 (pt) | 2022-01-18 |
| US20220162162A1 (en) | 2022-05-26 |
| KR20220024780A (ko) | 2022-03-03 |
| EP3986862B1 (en) | 2024-01-24 |
| JP2025004155A (ja) | 2025-01-14 |
| MA56506A (fr) | 2022-04-27 |
| AU2020298031A1 (en) | 2022-02-03 |
| KR102871719B1 (ko) | 2025-10-15 |
| IL288990B2 (en) | 2025-09-01 |
| CA3143112A1 (en) | 2020-12-24 |
| JP7699551B2 (ja) | 2025-06-27 |
| US11565998B2 (en) | 2023-01-31 |
| EP4360708A2 (en) | 2024-05-01 |
| IL288990B1 (en) | 2025-05-01 |
| CN113993842A (zh) | 2022-01-28 |
| CN113993842B (zh) | 2024-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202004729B (en) | Pharmaceutical compounds | |
| ZA202201364B (en) | Deuterated compounds for use in the treatment of cancer | |
| PH12019502245A1 (en) | Compounds that inhibit mcl-1 protein | |
| TN2018000119A1 (en) | Dihydroimidazopyrazinone derivatives useful in the treatment of cancer | |
| SG10201907164SA (en) | Rna containing composition for treatment of tumor diseases | |
| AU2018231032A8 (en) | JAK inhibitors containing a 4-membered heterocyclic amide | |
| PH12017500367B1 (en) | Compounds that inhibit mcl-1 protein | |
| GEP20166484B (en) | Protein kinase inhibitors | |
| TN2018000276A1 (en) | Inhibitors of receptor-interacting protein kinase 1. | |
| JOP20210128A1 (ar) | مركبات عطرية غير متجانسة كمثبطات Vanin | |
| MX2017006649A (es) | Derivados de triazolo-pirazinilo utiles como activadores de guanilato ciclasa soluble. | |
| PH12019502693A1 (en) | Heteroaromatic compounds as vanin inhibitors | |
| CR20210101A (es) | Compuestos heteroaromáticos como inhibidores de vanina | |
| PH12021553233A1 (en) | Imidazopyrimidines as eed inhibitors and the use thereof | |
| PH12018502497A1 (en) | Adenosine derivatives for use in the treatment of cancer | |
| MY194116A (en) | Pharmaceutical compounds | |
| PH12019500460A1 (en) | Imidazole derivatives and their use in the treatment of autoimmune or inflammatory diseases or cancers | |
| TN2020000050A1 (en) | Novel phenylpyridine derivative and pharmaceutical composition containing same | |
| MX2021015137A (es) | Profarmaco de succinato, composiciones que contienen profarmaco de succinato y usos de los mismos. | |
| MX2021006490A (es) | Compuestos heteroaromaticos como inhibidores de vanina. | |
| PH12019502170A1 (en) | Combination of isoindolinone derivatives with sgi-110 | |
| MX385475B (es) | Derivados de piridoquinazolina eficaces como inhibidores de proteina quinasa | |
| MX2019014438A (es) | Derivados de acidos carboxilicos eficaces como inhibidores de la proteina quinasa. | |
| MX2018001307A (es) | Compuesto de pirrolo[2,3-d]pirimidina o sal del mismo. | |
| EA201992303A1 (ru) | СОЕДИНЕНИЯ, КОТОРЫЕ ИНГИБИРУЮТ БЕЛОК Mcl-1 |